These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27330062)

  • 1. New insights into the regulatory pathways associated with the activation of the stringent response in bacterial resistance to the PBP2-targeted antibiotics, mecillinam and OP0595/RG6080.
    Doumith M; Mushtaq S; Livermore DM; Woodford N
    J Antimicrob Chemother; 2016 Oct; 71(10):2810-4. PubMed ID: 27330062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam 'enhancer'.
    Morinaka A; Tsutsumi Y; Yamada M; Suzuki K; Watanabe T; Abe T; Furuuchi T; Inamura S; Sakamaki Y; Mitsuhashi N; Ida T; Livermore DM
    J Antimicrob Chemother; 2015 Oct; 70(10):2779-86. PubMed ID: 26089439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of OP0595, a Novel Triple-Action Diazabicyclooctane, with β-Lactams against OP0595-Resistant Enterobacteriaceae Mutants.
    Livermore DM; Warner M; Mushtaq S; Woodford N
    Antimicrob Agents Chemother; 2016 Jan; 60(1):554-60. PubMed ID: 26552987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of PBP1B and LpoB in
    Thulin E; Andersson DI
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of OP0595/β-lactam combinations against Gram-negative bacteria with extended-spectrum, AmpC and carbapenem-hydrolysing β-lactamases.
    Livermore DM; Mushtaq S; Warner M; Woodford N
    J Antimicrob Chemother; 2015 Nov; 70(11):3032-41. PubMed ID: 26311835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Mutations in the
    Ranjitkar S; Reck F; Ke X; Zhu Q; McEnroe G; Lopez SL; Dean CR
    mSphere; 2019 Jul; 4(4):. PubMed ID: 31270174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Characterization of Diazabicyclooctane β-Lactam "Enhancers" in Complex with Penicillin-Binding Proteins PBP2 and PBP3 of Pseudomonas aeruginosa.
    Rajavel M; Kumar V; Nguyen H; Wyatt J; Marshall SH; Papp-Wallace KM; Deshpande P; Bhavsar S; Yeole R; Bhagwat S; Patel M; Bonomo RA; van den Akker F
    mBio; 2021 Feb; 12(1):. PubMed ID: 33593978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of nacubactam (RG6080/OP0595) combinations against MBL-producing Enterobacteriaceae.
    Mushtaq S; Vickers A; Woodford N; Haldimann A; Livermore DM
    J Antimicrob Chemother; 2019 Apr; 74(4):953-960. PubMed ID: 30590470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mecillinam resistome reveals a role for peptidoglycan endopeptidases in stimulating cell wall synthesis in Escherichia coli.
    Lai GC; Cho H; Bernhardt TG
    PLoS Genet; 2017 Jul; 13(7):e1006934. PubMed ID: 28749938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo activities of the diazabicyclooctane OP0595 against AmpC-derepressed Pseudomonas aeruginosa.
    Morinaka A; Tsutsumi Y; Yamada K; Takayama Y; Sakakibara S; Takata T; Abe T; Furuuchi T; Inamura S; Sakamaki Y; Tsujii N; Ida T
    J Antibiot (Tokyo); 2017 Mar; 70(3):246-250. PubMed ID: 27999441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penicillin binding protein 2 is dispensable in Escherichia coli when ppGpp synthesis is induced.
    Vinella D; D'Ari R; Jaffé A; Bouloc P
    EMBO J; 1992 Apr; 11(4):1493-501. PubMed ID: 1563353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro and In Vivo Activities of OP0595, a New Diazabicyclooctane, against CTX-M-15-Positive Escherichia coli and KPC-Positive Klebsiella pneumoniae.
    Morinaka A; Tsutsumi Y; Yamada K; Takayama Y; Sakakibara S; Takata T; Abe T; Furuuchi T; Inamura S; Sakamaki Y; Tsujii N; Ida T
    Antimicrob Agents Chemother; 2016 May; 60(5):3001-6. PubMed ID: 26953205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Insights into the TLA-3 Extended-Spectrum β-Lactamase and Its Inhibition by Avibactam and OP0595.
    Jin W; Wachino JI; Yamaguchi Y; Kimura K; Kumar A; Yamada M; Morinaka A; Sakamaki Y; Yonezawa M; Kurosaki H; Arakawa Y
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and Mechanism of Spontaneous Resistance to Sulbactam Combined with the Novel β-Lactamase Inhibitor ETX2514 in Clinical Isolates of Acinetobacter baumannii.
    McLeod SM; Shapiro AB; Moussa SH; Johnstone M; McLaughlin RE; de Jonge BLM; Miller AA
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Basis for E. coli Penicillin Binding Protein (PBP) 2 Inhibition, a Platform for Drug Design.
    Levy N; Bruneau JM; Le Rouzic E; Bonnard D; Le Strat F; Caravano A; Chevreuil F; Barbion J; Chasset S; Ledoussal B; Moreau F; Ruff M
    J Med Chem; 2019 May; 62(9):4742-4754. PubMed ID: 30995398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased energy demand from anabolic-catabolic processes drives β-lactam antibiotic lethality.
    Lobritz MA; Andrews IW; Braff D; Porter CBM; Gutierrez A; Furuta Y; Cortes LBG; Ferrante T; Bening SC; Wong F; Gruber C; Bakerlee CW; Lambert G; Walker GC; Dwyer DJ; Collins JJ
    Cell Chem Biol; 2022 Feb; 29(2):276-286.e4. PubMed ID: 34990601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cell lysis in Escherichia coli: cooperative effect of nocardicin A and mecillinam.
    Berenguer J; de Pedro MA; Vázquez D
    Antimicrob Agents Chemother; 1982 Feb; 21(2):195-200. PubMed ID: 6280596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Pharmacokinetics of the Combination of OP0595 and Cefepime in a Mouse Model of Pneumonia Caused by Extended-Spectrum-Beta-Lactamase-Producing Klebsiella pneumoniae.
    Kaku N; Kosai K; Takeda K; Uno N; Morinaga Y; Hasegawa H; Miyazaki T; Izumikawa K; Mukae H; Yanagihara K
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28507106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mecillinam resistance in Escherichia coli is conferred by loss of a second activity of the AroK protein.
    Vinella D; Gagny B; Joseleau-Petit D; D'Ari R; Cashel M
    J Bacteriol; 1996 Jul; 178(13):3818-28. PubMed ID: 8682786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron limitation induces SpoT-dependent accumulation of ppGpp in Escherichia coli.
    Vinella D; Albrecht C; Cashel M; D'Ari R
    Mol Microbiol; 2005 May; 56(4):958-70. PubMed ID: 15853883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.